Minova Life Science

Minova life sciences - Pharmaceutical company

Minolet-A Tablets

COMPOSITION – Clopidogrel  IP 75mg + Aspirin  IP 75mg

  • Demonstrates protection against major cardiovascular events, myocardial infarction and stroke to a significant extent as compared to monotherapy!
  • Addition of clopidogrel to aspirin therapy demonstrated a significant decrease in the risk of major vascular events such as stroke
  • Demonstrates a significant decrease in the rate of recurrent cardiovascular events in patients after percutaneous coronary intervention
  • More effective in venous graft patency than aspirin alone in patients after coronary artery bypass grafting (CABG)

Explore other products

Scroll to Top